Clinical Trials for Well-Differentiated Neuroendocrine Carcinoma

Find clinical trials for well-differentiated neuroendocrine carcinoma. Discover research opportunities and treatment options in your area.

1 Active Trial Found

Showing 1 trial on this page

Page 1 of 1

Lenvatinib Plus Pembrolizumab in Well Differentiated G3 Neuroendocrine Tumors

NCT ID: NCT05746208

This clinical trial is investigating the combination of two medications, lenvatinib and pembrolizumab, for treating a specific type of cancer called well-differentiated grade 3 neuroendocrine tumor...

Recruiting

Phase: PHASE2 Type: interventional Locations: San Francisco, California, United States

Related Conditions

Breast Cancer View clinical trials → Stroke View clinical trials → Obesity View clinical trials → Cancer View clinical trials → Prostate Cancer View clinical trials → Healthy View clinical trials →

Search All Trials Browse All Conditions